In8Bio INAB
NASDAQ INAB
$1.10 +0.02 (+1.85%)
At close: Sep 10, 2026 · 4:00 PM EDT

In8Bio (INAB) Net Shares Issued and Repurchased (2021 - 2026)

In8Bio's (INAB) quarterly Net Shares Issued and Repurchased came in at $490500.0 in Q1 2026, down 82.74% year-over-year from $2.8 million in Q1 2025, and up 356.99% quarter-over-quarter from $107333.0 in Q4 2025.

Analysis

In8Bio (INAB) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

In8Bio has disclosed Net Shares Issued and Repurchased across 6 years of filings, most recently posting $490500.0 for Q1 2026.

  • In Q1 2026, Net Shares Issued and Repurchased fell 82.74% year-over-year to $490500.0; the TTM figure through Mar 2026 stood at $490500.0 (down 82.74% YoY), while the FY2025 annual figure was $107333.0, down 98.32% from the prior year.
  • Net Shares Issued and Repurchased came in at $490500.0 for Q1 2026 at In8Bio, up from $107333.0 in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $6.4 million in Q4 2024 to a low of $107333.0 in Q4 2025.
  • Average Net Shares Issued and Repurchased over 5 years is $1.9 million, with a median of $1.7 million recorded in 2024.
  • Year-over-year, Net Shares Issued and Repurchased soared 900.16% in 2024 and slumped 98.32% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $1.8 million in 2022, then surged by 62.38% to $3.0 million in 2023, then surged by 113.15% to $6.4 million in 2024, then tumbled by 98.32% to $107333.0 in 2025, then jumped by 356.99% to $490500.0 in 2026.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $490500.0 in Q1 2026, $107333.0 in Q4 2025, and $2.8 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn -
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn -
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -
6 Beam Therapeutics 2.55 Bn 2.55 Bn - -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn -
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn -
10 In8Bio 21.41 Mn 21.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 490,500.00
Dec 31, 2025 107,333.00
Mar 31, 2025 2.84 Mn
Dec 31, 2024 6.39 Mn
Mar 31, 2024 1.69 Mn
Dec 31, 2023 3.00 Mn
Mar 31, 2023 169,040.00
Dec 31, 2022 1.85 Mn
Mar 31, 2022 801,600.00
Dec 31, 2021 1.23 Mn